Table 1. Parkinson's diseased subjects' characteristics.
| Subject ID | Group | Age | Sex | Hoehn and Yahr | Medications |
| 1 | Advanced | 64 | Male | 2.5 | Sinemet; Amantadine |
| 2 | Advanced | 71 | Male | 2.5 | Sinemet |
| 3 | Mild | 61 | Female | 2 | Mirapex |
| 4 | Mild | 75 | Male | 2 | Sinemet |
| 5 | Mild | 70 | Female | 1.5 | Levodopa; Ropinirole |
| 6 | Mild | 72 | Female | 2 | Sinemet |
| 7 | Mild | 57 | Female | 2 | Sinemet; Ropinirole |
| 8 | Mild | 61 | Female | 2 | Sinemet; Amantidine |
| 9 | Mild | 50 | Female | 1 | Carbidopa; Mirapex; Amantidine |
| 10 | Advanced | 74 | Male | 2.5 | Sinemet |
| 11 | Mild | 65 | Male | 2 | Sinemet |
| 12 | Advanced | 75 | Female | 4 | Sinemet |
| 13 | Advanced | 84 | Female | 4 | Sinemet |
| 15 | Advanced | 67 | Male | 3 | Sinemet |